Clinical Trial Update: Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced Solid Tumours [NA]

View source ↗

Summary

A clinical trial evaluating Tumour Treatment Vaccine (TTV) in combination with a PD-1 inhibitor for relapsed/refractory advanced solid tumors is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PD-1 inhibitor
• Tumour Treatment Vaccine (TTV) (Tumour Treatment Vaccine)

Snippet

Sponsor: Wuxi People's Hospital | Conditions: Cancer, PD-L1 Gene Mutation | NA | Status: RECRUITING